El pilar I es en donde se engloban los proyectos más competitivos, los clásicos proyectos colaborativos de anteriores Programas Marcos y que agrupan a investigadores, empresas, centros de investigación y universidades
Name | Opening date | Next deadline | Deadline model | Link |
Safe & Sustainable by Design (SSbD) packaging and single use device solutions for healthcare products | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Inclusive clinical studies for equitable access to clinical research in Europe | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
: Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
European Partnership on Rare Diseases | 12 January 2023 | 19 Sep. 2023 | single-stage | |
Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Access to health and care services for people in vulnerable situations | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Innovative non-animal human-based tools and strategies for biomedical research | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Personalised prevention of non-communicable diseases – addressing areas of unmet needs using multiple data sources | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage | |
Advancing point-of-care diagnostics to the market | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage | |
Bio-printing of living cells for regenerative medicine | 26/10/2023 | 11/04/2024 | single-stage | |
Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) | 26/10/2023 | 11/04/2024 | single-stage | |
Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators | 26/10/2023 | 11/04/2024 | single-stage | |
Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness | 26/10/2023 | 11/04/2024 | single-stage | |
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential | 26/10/2023 | 11/04/2024 | single-stage |
Ámbito: Europa
Presupuesto: 8.246 M€
Organismo: Comisión europea
Naturaleza de proyecto: I+D+i
Cualquier tipo de organización puede solicitar la financiación de Horizon Europe siempre que tenga la capacidad operativa y financiera para llevar a cabo las tareas que propone.
Variables
Costes directo e indirectos relacionados con el ámbito del programa.
¿Cómo alcanzar el máximo éxito en la gestión de fondos europeos? Chiara AssirelliSettings Gestionar eficazmente las subvenciones de la Unión Europea (UE) es crucial para las organizaciones que desean financiar sus proyectos o iniciativas. Las
Se pretende financiar las actividades I+D de las empresas regionales para favorecer su consolidación y crecimiento, propiciando asimismo la colaboración con el resto de los agentes del ecosistema regional de I+D+i, para alcanzar mayores cotas de competitividad empresarial, creación de riqueza y empleo, lo que supone en última instancia un fin de interés económico regional.
El instrumento I3 pretende promover la innovación a través de la especialización inteligente y la colaboración interregional.
El Fondo Europeo de Pesca Marítima y Acuicultura (EMFAF) apoya la implementación de la política pesquera común, la política marítima de la UE y la agenda de la UE para la gobernanza internacional de los océanos.